MAGELLAN LONGEVITY
HomeResearchStudy library › Complications of Diabetes and Metrics of Glycemic Management Derived…
Study summary · Metabolic health, glucose & body composition

What is the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications?

In one paragraph

Continuous Glucose Monitoring, studied in 20852 participants (J Clin Endocrinol Metab 2022, PMID 35094087) — glycemic variability and low time in range (TIR) were associated with all studied microvascular and macrovascular complications of diabetes. More longitudinal studies and trials are needed to confirm these associations, especially for type 1 diabetes, where data are limited.

Source: J Clin Endocrinol Metab 2022, PMID 35094087 ↗ · Research map · How Magellan grades evidence · evidence confidence: low

J Clin Endocrinol Metab · 2022 · PMID 35094087 · DOI 10.1210/clinem/dgac034

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Continuous glucose monitoring metrics, especially Time in Range, are associated with diabetes complications and may offer better insights than HbA1c alone.

The question

What is the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications?

What they tested

The study implicitly hypothesizes that CGM-derived metrics, beyond HbA1c, are associated with diabetes complications and can provide insight into short-term glucose fluctuations.

How they did it

A systematic review was conducted by searching PubMed and Embase databases from January 1, 2010, to August 22, 2020. The search terms included 'type 1 diabetes', 'type 2 diabetes', 'diabetes-related microvascular and macrovascular complications', and 'measures of glycaemic variability'. Studies not using CGM or involving non-diabetic, acutely unwell, pregnant participants, or those using insulin pumps were excluded. The final review included 34 publications out of 1636 identified records, encompassing 20852 participants (663 with T1D and 19909 with T2D).

What they found

Glycemic variability and low time in range (TIR) were associated with all studied microvascular and macrovascular complications of diabetes. Higher TIR was specifically linked to a reduced risk of albuminuria, retinopathy, cardiovascular disease mortality, all-cause mortality, and abnormal carotid intima-media thickness. Peripheral neuropathy was primarily associated with the standard deviation of blood glucose levels (SD) and mean amplitude of glycemic excursions (MAGE).

What it means

The evidence supports an association between diabetes complications and CGM-derived measures of intraday glycemic variability. Time in range (TIR) was the most consistent measure, suggesting its growing importance in clinical practice.

Limitations

More longitudinal studies and trials are needed to confirm these associations, especially for type 1 diabetes, where data are limited.

“higher time in range was associated with reduced cardiovascular and all-cause mortality”— from the published abstract, J Clin Endocrinol Metab 2022

The paper at a glance

TitleComplications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring
JournalJ Clin Endocrinol Metab
Year2022
PMID35094087 ↗
DOI10.1210/clinem/dgac034 ↗
TopicMetabolic health, glucose & body composition

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Continuous Glucose Monitoring (CGM)

In randomized trials and meta-analyses, continuous and flash glucose monitoring modestly lowers HbA1c (about 0.2–0.3 percentage points on average) and, more strikingly, cuts time spent in hypoglycemia—by 38% in type 1 diabetes and by roughly half in insulin-treated type 2 diabetes—compared with fingerstick testing;

FreeStyle Libre CGM

The FreeStyle Libre is a factory-calibrated, intermittently scanned ("flash") continuous glucose…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What is the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications? [Plain-English summary of J Clin Endocrinol Metab 2022, PMID 35094087, DOI 10.1210/clinem/dgac034]. Magellan Longevity. https://magellanlongevity.com/study/x12.html
BibTeX
@misc{magellan_x12, title = {What is the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/x12.html}}, note = {Plain-English summary of PubMed PMID 35094087; DOI 10.1210/clinem/dgac034; J Clin Endocrinol Metab 2022. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/x12.html

Related studies in the Magellan library

All 22 Magellan summaries on metabolic health, glucose & body composition →

How this summary was made. Every section above restates what the published abstract of PMID 35094087 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.